Citations

Mayo Clinic

Showing 10 of 108599 citations.

Neuromodulation for the management of chronic pelvic pain syndromes: A systematic review
Gish, Brandon , Sobey, Christopher M., Singh, Chahait, Abdullah, Newaj , Walker, Jeremy, Gray, Hannah, Hagedorn, Jonathan M. , Ghosh, Priyanka , Patel, Kiran V., Hagedorn, Jonathan M , Ghosh, Priyanka , Deer, Tim , Gish, Brandon , Langford, Brendan , Deer, Timothy R.

Pain Practice | September 20, 2023 | Volume: 24 | Issue: 2 | Pages: 321-340

10.1111/papr.13295 | PMID 37726930 Get It

AbstractBackgroundChronic pelvic pain is a burdensome condition that involves multiple medical sub‐specialties and is often difficult to treat. Sacral stimulation for functional bladder disease has been well established, but little large‐scale evidence exists regarding utilization of other neuromodulation techniques to treat chronic pelvic pain. Emerging evidence does suggest that neuromodulation is a promising treatment, and we aim to characterize the use and efficacy of such techniques for treating chronic pelvic pain syndromes.Materials and MethodsA systematic review of the literature demonstrating the treatment of chronic pelvic pain syndromes with neuromodulation. Abstracts were reviewed and selected for inclusion, including case series, prospective studies, and randomized controlled trials (RCTs). Case studies and publications in abstract only were not included. The reporting for this systematic review follows Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA). The literature search was performed using MEDLINE, Embase, Cochrane Library, PubMed, CINAHL, and Scopus.ResultsA total of 50 studies were included in this review, three of which were randomized controlled trials, and the remaining were prospective and retrospective case series. The range of pelvic pain conditions treated included interstitial cystitis, peripheral neuralgia, pudendal neuralgia, gastrointestinal pain, urogenital pain, sacroiliac joint pain, and visceral chronic pelvic pain. We reported on outcomes involving pain, functionality, psychosocial improvement, and medication reduction.ConclusionsNeuromodulation is a growing treatment for various chronic pain syndromes. Peripheral nerve stimulation was the least studied form of stimulation. Posterior tibial nerve stimulation appears to offer short‐term benefit, but long‐term results are challenging. Sacral nerve stimulation is established for use in functional bladder syndromes and appears to offer pain improvement in these patients as well. Dorsal root ganglion stimulation and spinal cord stimulation have been used for a variety of conditions with promising results. Further studies of homogeneous patient populations are necessary before strong recommendations can be made at this time, although pooled analysis may also be impactful.
Artificial Intelligence Models in Health Information Exchange: A Systematic Review of Clinical Implications
Maniaci, Michael J. , Haider, Clifton R. , Maita, Karla C. , Lunde, Julianne J. , Coffey, Jordan , Forte, Antonio J. , Maniaci, Michael J , Torres-Guzman, Ricardo A, Coffey, Jordan D , Forte, Antonio Jorge , Borna, Sahar , Torres‐Guzman, Ricardo A. , Ávila, Francisco R. , Demaerschalk, Bart M.

Healthcare | September 19, 2023 | Volume: 11 | Issue: 18 | Pages: 2584

10.3390/healthcare11182584 | PMID 37761781 Get It

Electronic health record (EHR) systems collate patient data, and the integration and standardization of documents through Health Information Exchange (HIE) play a pivotal role in refining patient management. Although the clinical implications of AI in EHR systems have been extensively analyzed, its application in HIE as a crucial source of patient data is less explored. Addressing this gap, our systematic review delves into utilizing AI models in HIE, gauging their predictive prowess and potential limitations. Employing databases such as Scopus, CINAHL, Google Scholar, PubMed/Medline, and Web of Science and adhering to the PRISMA guidelines, we unearthed 1021 publications. Of these, 11 were shortlisted for the final analysis. A noticeable preference for machine learning models in prognosticating clinical results, notably in oncology and cardiac failures, was evident. The metrics displayed AUC values ranging between 61% and 99.91%. Sensitivity metrics spanned from 12% to 96.50%, specificity from 76.30% to 98.80%, positive predictive values varied from 83.70% to 94.10%, and negative predictive values between 94.10% and 99.10%. Despite variations in specific metrics, AI models drawing on HIE data unfailingly showcased commendable predictive proficiency in clinical verdicts, emphasizing the transformative potential of melding AI with HIE. However, variations in sensitivity highlight underlying challenges. As healthcare’s path becomes more enmeshed with AI, a well-rounded, enlightened approach is pivotal to guarantee the delivery of trustworthy and effective AI-augmented healthcare solutions.
Development and Validation of an XGBoost-Algorithm-Powered Survival Model for Predicting In-Hospital Mortality Based on 545,388 Isolated Severe Traumatic Brain Injury Patients from the TQIP Database
Cao, Yang , Forssten, Maximilian Peter , Montgomery, Scott , Montgomery, Scott , Sarani, Babak , Mohseni, Shahin

Journal of Personalized Medicine | September 19, 2023 | Volume: 13 | Issue: 9 | Pages: 1401

10.3390/jpm13091401 | PMID 37763168 Get It

Background: Traumatic brain injury (TBI) represents a significant global health issue; the traditional tools such as the Glasgow Coma Scale (GCS) and Abbreviated Injury Scale (AIS) which have been used for injury severity grading, struggle to capture outcomes after TBI. Aim and methods: This paper aims to implement extreme gradient boosting (XGBoost), a powerful machine learning algorithm that combines the predictions of multiple weak models to create a strong predictive model with high accuracy and efficiency, in order to develop and validate a predictive model for in-hospital mortality in patients with isolated severe traumatic brain injury and to identify the most influential predictors. In total, 545,388 patients from the 2013–2021 American College of Surgeons Trauma Quality Improvement Program (TQIP) database were included in the current study, with 80% of the patients used for model training and 20% of the patients for the final model test. The primary outcome of the study was in-hospital mortality. Predictors were patients’ demographics, admission status, as well as comorbidities, and clinical characteristics. Penalized Cox regression models were used to investigate the associations between the survival outcomes and the predictors and select the best predictors. An extreme gradient boosting (XGBoost)-powered Cox regression model was then used to predict the survival outcome. The performance of the models was evaluated using the Harrell’s concordance index (C-index). The time-dependent area under the receiver operating characteristic curve (AUC) was used to evaluate the dynamic cumulative performance of the models. The importance of the predictors in the final prediction model was evaluated using the Shapley additive explanations (SHAP) value. Results: On average, the final XGBoost-powered Cox regression model performed at an acceptable level for patients with a length of stay up to 250 days (mean time-dependent AUC = 0.713) in the test dataset. However, for patients with a length of stay between 20 and 213 days, the performance of the model was relatively poor (time-dependent AUC < 0.7). When limited to patients with a length of stay ≤20 days, which accounts for 95.4% of all the patients, the model achieved an excellent performance (mean time-dependent AUC = 0.813). When further limited to patients with a length of stay ≤5 days, which accounts for two-thirds of all the patients, the model achieved an outstanding performance (mean time-dependent AUC = 0.917). Conclusion: The XGBoost-powered Cox regression model can achieve an outstanding predictive ability for in-hospital mortality during the first 5 days, primarily based on the severity of the injury, the GCS on admission, and the patient’s age. These variables continue to demonstrate an excellent predictive ability up to 20 days after admission, a period of care that accounts for over 95% of severe TBI patients. Past 20 days of care, other factors appear to be the primary drivers of in-hospital mortality, indicating a potential window of opportunity for improving outcomes.
Sexual and Gender Minority Invisibility in Cancer Studies: A Call for Effective Recruitment Methods to Address Cancer Disparities
Rosser, B. R. Simon , Weideman, Ben C. D. , Rider, G. Nic , Jatoi, Aminah , Ecklund, Alexandra M. , Wheldon, Christopher W. , Talley, Kristine Mc , Kulasingam, Shalini , Smith, M. Kumi , Jacobs, David R. , West, William , Alley, Rhea , Talley, Kristine M C , Mitteldorf, Darryl , Ross, Michael W , Rider, G. Nic , Jacobs, David R

Journal of Clinical Oncology | September 19, 2023 | Volume: 41 | Issue: 33 | Pages: 5093-5098

10.1200/jco.23.00655 | PMID 37725780 Get It

#LGBTQ+ people with cancer are invisibilized: A call for #intersectional cancer research (link here) #healthequity
Nucleotide-free structures of KIF20A illuminate atypical mechanochemistry in this kinesin-6
Ranaivoson, F.M. , Crozet, Vincent , Benoit, Matthieu P. M. H. , Khalid, Amna Abdalla Mohammed, Kikuti, Carlos , Sirkia, Helena , Marjou, Ahmed El , Miserey‐Lenkei, Stéphanie , Asenjo, Ana B. , Sosa, Hernando , Rosenfeld, Steven S. , Houdusse, Anne , Ranaivoson, Fanomezana Moutse , El Marjou, Ahmed , Schmidt, Christoph F , Rosenfeld, Steven S , Houdusse, Anne

Open Biology | September 19, 2023 | Volume: 13 | Issue: 9 | Pages: No page available

10.1098/rsob.230122 | PMID 37726093 Get It

KIF20A is a critical kinesin for cell division and a promising anti-cancer drug target. The mechanisms underlying its cellular roles remain elusive. Interestingly, unusual coupling between the nucleotide- and microtubule-binding sites of this kinesin-6 has been reported, but little is known about how its divergent sequence leads to atypical motility properties. We present here the first high-resolution structure of its motor domain that delineates the highly unusual structural features of this motor, including a long L6 insertion that integrates into the core of the motor domain and that drastically affects allostery and ATPase activity. Together with the high-resolution cryo-electron microscopy microtubule-bound KIF20A structure that reveals the microtubule-binding interface, we dissect the peculiarities of the KIF20A sequence that influence its mechanochemistry, leading to low motility compared to other kinesins. Structural and functional insights from the KIF20A pre-power stroke conformation highlight the role of extended insertions in shaping the motor's mechanochemical cycle. Essential for force production and processivity is the length of the neck linker in kinesins. We highlight here the role of the sequence preceding the neck linker in controlling its backward docking and show that a neck linker four times longer than that in kinesin-1 is required for the activity of this motor.
Walter Michael Kuehl, MD - October 25, 1939 - April 30, 2023
Bergsagel, Leif, Bergsagel, P. Leif , Bergsagel, P. Leif

Clinical Hematology International | September 19, 2023 | Volume: 5 | Issue: 4 | Pages: No page available

10.46989/001c.87881 Get It

Early Bowel Obstruction after Bariatric Surgery: An Analysis of the 2020-2021 MBSAQIP Database
Clapp, Benjamin , Corbett, John , Salame, Marita , Hage, Karl , Zundel, Natán , Ghanem, Omar M. , Abi Mosleh, Kamal , Mosleh, Kamal Abi , Kurian, Marina S.

Surgical Laparoscopy, Endoscopy & Percutaneous Techniques | September 19, 2023 | Volume: 33 | Issue: 5 | Pages: 499-504

10.1097/sle.0000000000001227 | PMID 37725818 Get It

Background: The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program evaluates 30-day outcomes of bariatric cases performed in the United States. The Participant Use File in 2020 introduced bowel obstruction (BO). We compared the rates of BO, risk factors, and postoperative outcomes after laparoscopic Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and duodenal switch (DS). Methods: Retrospective analysis of patients who underwent laparoscopic RYGB, SG, or DS obtained from the 2020-2021 Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program. Patients who underwent either as a primary procedure with a body mass index >35 kg/m2 were selected. Baseline characteristics, operative details, and postoperative complications were collected. The outcome of interest was BO occurring within 30 days. Results: A total of 205,533 cases of which 148,944 were SG (72.4%), 54,606 were RYGB (26.5%), and 1983 were DS (1%). BO occurred in 0.74%, 0.4%, and 0.03% of patients who underwent an RYGB, DS, or SG, respectively. Patients with a BO in the RYGB group were more likely to be on immunosuppressive therapy (5.4% vs. 1.9%, P<0.001) with longer operative time (136.2 min±58.0 min vs. 117.4 min±53.6 min, P<0.001). SG patients with a BO were older (47.5±13.6 vs. 41.9±11.6, P=0.011) with longer operating times (98.6±63.8 vs. 68.9±33.4, P=0.002). Patients in the RYGB group with a BO had the highest rates of readmissions (71.9%) and reoperations (58.4%). Conclusions: Early bowel obstruction is rare after bariatric surgery. It is more common after RYGB and least common after SG. Readmission and reoperation rates were highest in patients with BO in the RYGB group.
Early Identification of Individuals at Risk for Hypertensive Disorders of Pregnancy
Santos, Janelle, Schenone, Mauro , Schenone, Mauro H , Garovic, Vesna D.

JAMA Network Open | September 19, 2023 | Volume: 6 | Issue: 9 | Pages: e2334858

10.1001/jamanetworkopen.2023.34858 | PMID 37725380 Get It

Obesity management for the hepatologist—What to do, how to do it and why?
Watt, Kymberly D. , Paul, Sonali , Khan, Mohammad Qasim , Siddiqui, Mohammad Shadab , Lam, Jenny , Diwan, Tayyab S. , Camilleri, Michael , Khan, Mohammad Qasim

Hepatology | September 19, 2023 | Volume: 81 | Issue: 5 | Pages: 1607-1620

10.1097/hep.0000000000000598 | PMID 37725761 Get It

Obesity is highly prevalent in hepatology clinics and has a significant impact on chronic liver disease and patient management. Hepatologists and gastroenterologists need to be actively engaged in the management of obesity. This review provides a detailed approach to this challenging comorbidity.
Optimal measurement of gastric emptying of solids in gastroparesis or functional dyspepsia: evidence to establish standard test
Camilleri, Michael , Zheng, Ting , Vosoughi, Kia , Lupianez‐Merly, Camille , Eckert, Deborah J., Busciglio, Irene, Burton, Duane D. , Dilmaghani, Saam , Eckert, Deborah, Burton, Duane

Gut | September 19, 2023 | Volume: 72 | Issue: 12 | Pages: 2241-2249

10.1136/gutjnl-2023-330733 | PMID 37726164 Get It

Objective Symptoms in gastroparesis (Gp) and functional dyspepsia (FD) overlap; using egg protein substitute to measure gastric emptying of solids (GES), ~40% of patients are reclassified from Gp to FD, and vice versa. Our aim was to assess inter-individual and intra-individual coefficients of variation (COV) in GES in symptomatic patients with Gp or FD with documented slow or normal GES, respectively. Design Scintigraphic GES (T1/2 and GE% at 2 and 4 hours) using a 320 kcal real egg meal (30% fat) was tested in the following: single measurements in 20 patients with diabetes mellitus (10 each type 1 and type 2); repeat GES to estimate COVintra measured: 3 days apart in 9 Gp, 4 weeks apart in 21 Gp and 18 with FD with normal GE assigned to placebo and in 70 patients at 94.3 weeks (median) apart. Results COVinter for GE% at 4 hours and GE T1/2 were respectively 14.2% and 23.5% in FD and 27.5% and 33% in Gp; COVintra for GE% at 4 hours and GE T1/2 up to 4 weeks apart were 23.4% and 37.9% in FD and 20.1% and 33% in Gp. GE% at 2 hours showed less consistent results. However, >85% retained original diagnosis as normal or delayed. From clinical GES to baseline research for Gp group, repeat GES (after treatment) showed the COVintra for GE% at 4 hours was 37.3% at median 94.3 weeks, with 26/70 changed diagnoses. Conclusion The 320 kcal (30% fat) GES scintigraphic test provides consistent diagnosis in >85% and should be the standard test for suspected gastric emptying disorders.